CVIR Endovascular

Table 1 Baseline demographic, clinical, and lesion characteristics of 970 patients

From: Intravascular ultrasound-based decision tree model for the optimal endovascular treatment strategy selection of femoropopliteal artery disease—results from the ONION Study-

Age (years old)	74.1 ± 8.5
Male (%)	718 (74.0)
Hypertension(%)	750 (77.0)
Diabetes (%)	527 (54.3)
Dyslipidemia (%)	483 (49.8)
Current Smoking (%)	263 (27.1)
Obesity (%) BMI > 25^a	226 (23.2)
CRF (%)^a	294 (30.3)
ESRD^a on dialysis	230 (23.7)
Rutherford II	291 (30.0)
Rutherford III	679 (70.0)
ABI^a	0.65 ± 0.20
CTO^a (%)	369 (38.0)
Lesion length (mm)	144.4 ± 01
Popliteal artery alone (%)	56 (5.8)
Aspirin (%)	851 (87.7)
Clopidgrel (%)	747 (77.0)
Cilostazol (%)	232 (23.8)
OAC^a (%)	134 (13.8)
Statin (%)	397 (40.9)
Opticross IVUS (%)	391 (40.3)
AltaView IVUS (%)	380 (39.2)
Volcano IVUS (%)	196 (20.2)
Other IVUS (%)	3 (0.3)

^a ABI Ankle brachial index, BMI Body mass index, CRF Chronic renal failure, CTO Chronic total occlusion, ESRD End-stage renal dysfunction, OAC Oral anticoagulation therapy, IVUS Intravascular ultrasound

Back to article page